Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival

D Edler, U Kressner, P Ragnhammar, PG Johnston… - Clinical cancer …, 2000 - AACR
D Edler, U Kressner, P Ragnhammar, PG Johnston, I Magnusson, B Glimelius, L Påhlman…
Clinical cancer research, 2000AACR
Intratumoral thymidylate synthase (TS) expression and M r53, 000 phosphoprotein (p53)
overexpression were studied immunohistochemically in sections from stored paraffin-
embedded primary colorectal cancers in 70 patients who had undergone surgery during the
years 1987–1990. These cancers were classified according to Dukes' stage A–D, using
monoclonal antibodies TS 106 and DO-7. In patients with Dukes' stage A–C tumors,
univariate analyses showed that there was a significant correlation (P= 0.048) between …
Abstract
Intratumoral thymidylate synthase (TS) expression and Mr53,000 phosphoprotein (p53) overexpression were studied immunohistochemically in sections from stored paraffin-embedded primary colorectal cancers in 70 patients who had undergone surgery during the years 1987–1990. These cancers were classified according to Dukes’stage A–D, using monoclonal antibodies TS 106 and DO-7. In patients with Dukes’ stage A–C tumors, univariate analyses showed that there was a significant correlation (P = 0.048) between disease-free survival and TS expression and between TS expression and time to death with colorectal cancer (P = 0.038). In patients with Dukes’ stage A–D tumors, overall survival was correlated to TS expression (P = 0.015), Dukes’stage (P < 0.001), and level of tumor differentiation (P = 0.044) but not to p53 overexpression. Patients with low intratumoral TS expression survived significantly longer than patients with high expression. Cox multivariate analysis showed that Dukes’ stage (P < 0.001) and TS expression (P = 0.043) could independently serve as prognostic factors for time to death with colorectal cancer in patients with Dukes’ stage A–D tumors.
AACR